Engineered Gut Bacteria for Isoflavone Conversion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Only a fraction of the population possesses intestinal bacteria capable of converting dietary Daidzein from soy into Equol, a metabolite that offers health benefits including reduced risk of cardiovascular disease, due to limitations in natural gut microbiota composition.
Innovation Solution
Engineering the intestinal microbiota by introducing vectors encoding enzymes such as Daidzein reductase, Dihydrodaidzein racemase, and Tetrahydrodaidzein reductase into gut bacteria to convert Daidzein and Genistein into Equol and 5-Hydroxy-Equol, using engineered bacterial metabolic pathways and probiotics like E. coli strains.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If vectors encoding isoflavone metabolism pathways are introduced to gut bacteria, then the ability to convert Daidzein to Equol is improved, but the complexity of the bacterial system increases
Solution Approach 1:
The isoflavone metabolism pathway is divided into multiple sequential enzymatic steps, with each step encoded by a separate gene (daidzein reductase, dihydrodaidzein reductase, tetrahydrodaidzein reductase) that can be independently introduced via separate vectors or as a multi-gene construct. This segmentation allows for modular engineering of the metabolic pathway while maintaining the ability to convert Daidzein to Equol.
Solution Approach 2:
Engineered gut bacteria serve as intermediaries that facilitate the conversion of dietary Daidzein to Equol. The bacteria contain introduced genetic constructs that encode the necessary enzymes, acting as a biological mediator between the substrate (Daidzein) and the desired product (Equol), thereby resolving the contradiction between enhanced conversion ability and system complexity.
2Adaptability or versatility
If engineered genetic constructs are introduced to gut bacteria, then the Equol producing phenotype is achieved, but the stability of the bacterial community structure is worsened
Solution Approach 1:
The genetic constructs for isoflavone metabolism are pre-introduced into selected gut bacteria strains before administration to the host. This preliminary engineering ensures that the bacteria possess the necessary enzymatic machinery (daidzein reductase, dihydrodaidzein reductase, tetrahydrodaidzein reductase) to convert Daidzein to Equol, establishing the desired phenotype before the bacteria encounter the gut environment and compete with native microbiota.
Solution Approach 2:
The metabolic parameters of the gut bacteria are changed by introducing exogenous genes that encode specific enzymes for isoflavone conversion. This parameter change enables the bacteria to produce Equol from Daidzein, creating a new functional phenotype that enhances the host's ability to generate this beneficial metabolite without fundamentally disrupting the overall bacterial community structure.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables a broader population to achieve elevated serum Equol levels, mimicking the health benefits of natural Equol producers, thereby reducing cardiovascular disease risk through targeted gut microbiota modification.
Implementation Method 1
vectors encoding isoflavone metabolism pathways that can be included in bacteria to produce probiotics for modifying mammalian gut phenotype
Implementation Method 2
engineered bacterial metabolic pathway for enzymatic conversion of the isoflavones Daidzein and Genistein to the products Equol and 5-Hydroxy-Equol respectively
Data Source
AI summary
Generally, the present disclosure contemplates engineered vectors, organisms (e.g., bacteria or bacteriophage) containing the same, and methods for treating the gut of mammalian species by providing the organism containing the engineered vector to the gut of a mammal. Example engineered organisms can include one or more genes isolated from microbial populations for promoting isoflavone metabolism.